Status:
COMPLETED
Description of Changes in NIRS as a Function of Ductus Arteriosus Status in Very Premature Babies Born Before 32 WG at the DIJON University Hospital
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Extremely Premature Newborn (Born Before 32 Weeks' Gestation)
Eligibility:
All Genders
Up to 48 years
Brief Summary
Monitoring patent ductus arteriosus is currently performed using echocardiography, an operator-dependent examination which requires holding the child on their back and which is potentially time-consum...
Eligibility Criteria
Inclusion
- Parent who has agreed to participate in the study
- Very premature newborn (born before 32 weeks' gestation)
- Hospitalised in the Neonatal Intensive Care Unit at Dijon University Hospital
- Before 48 hours of life
Exclusion
- Newborn with congenital heart disease
- Newborn with a congenital renal anomaly
- Newborn with polymalformative syndrome
- Newborn with a skin anomaly
- Newborn with severe circulatory failure unrelated to the ductus arteriosus
Key Trial Info
Start Date :
October 16 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 14 2024
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT06153771
Start Date
October 16 2023
End Date
September 14 2024
Last Update
September 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Dijon Bourgogne
Dijon, France, 21000